Search

Your search keyword '"Diagnostic reagents industry -- Securities"' showing total 29 results
Start Over Descriptor "Diagnostic reagents industry -- Securities" Publisher the mcgraw-hill companies, inc.
29 results on '"Diagnostic reagents industry -- Securities"'

1. S&P Picks and Pans: Citigroup, Wells Fargo, ImClone, Royal Bank of Scotland, AMB Property; Analysts' opinions on stocks in the news Monday

Subjects
Diagnostic reagents industry -- Securities, Stocks -- Prices and rates, Financial services industry -- Securities, Banking industry -- Securities, Company securities, Company pricing policy, Financial services industry, Banking industry, Citigroup Inc. -- Securities, Wells Fargo & Co. -- Securities, ImClone Systems Inc. -- Securities
Published
2008

2. Why All the ImClone Interest? Its Pipeline; Big Pharma, hungry to fill thinning sales kits with better-protected oncology drugs, is circling Carl Icahn's hot property

Author

Arnst, Catherine

Subjects
Erbitux (Medication) -- Product information, Diagnostic reagents industry -- Product information, Diagnostic reagents industry -- Securities, Stocks -- Prices and rates, Company securities, Company pricing policy, ImClone Systems Inc. -- Product information, ImClone Systems Inc. -- Securities
Published
2008

4. IMCLONE'S NEW BIDDER

Author

Maurer, Harry and Linblad, Cristina

Subjects
Company securities, ImClone Systems Inc. -- Securities, Diagnostic reagents industry -- Securities
Published
2008

6. ICAHN RESISTS..

Author

Maurer, Harry and Linblad, Cristina

Subjects
Company acquisition/merger, Company securities, Bristol-Myers Squibb Co. -- Mergers, acquisitions and divestments, ImClone Systems Inc. -- Officials and employees, ImClone Systems Inc. -- Mergers, acquisitions and divestments, ImClone Systems Inc. -- Securities, Pharmaceutical industry -- Mergers, acquisitions and divestments, Diagnostic reagents industry -- Officials and employees, Diagnostic reagents industry -- Mergers, acquisitions and divestments, Diagnostic reagents industry -- Securities
Published
2008

7. Movers: Exxon Mobil, WaMu, ImClone Systems, Marathon Oil, Disney, MasterCard; Stocks in the news on Thursday

Subjects
Petroleum industry -- Securities, Diagnostic reagents industry -- Securities, Credit and debit card industry -- Securities, Transportation equipment industry -- Securities, Automobile industry -- Securities, Company securities, Automobile Industry, Motors Liquidation Co. -- Securities, Ford Motor Co. -- Securities, Chrysler L.L.C. -- Securities, Standard & Poor's Rating Services -- Securities, Exxon Mobil Corp. -- Securities, ImClone Systems Inc. -- Securities, MasterCard International Inc. -- Securities
Published
2008

8. S&P Picks and Pans: Wachovia, ImClone Systems, Weyerhaeuser, Red Hat, CBRL Group; Analysts' opinions on stocks in the news Monday

Subjects
Banking industry -- Forecasts and trends, Banking industry -- Securities, Diagnostic reagents industry -- Securities, Diagnostic reagents industry -- Forecasts and trends, Paper industry -- Securities, Paper industry -- Forecasts and trends, Company securities, Market trend/market analysis, Banking industry, Wachovia Corp. (Winston-Salem, North Carolina) -- Securities, Wachovia Corp. (Winston-Salem, North Carolina) -- Forecasts and trends, ImClone Systems Inc. -- Securities, ImClone Systems Inc. -- Forecasts and trends, Weyerhaeuser Co. -- Securities, Weyerhaeuser Co. -- Forecasts and trends
Published
2008

9. Analyst Actions: ImClone Systems, Blockbuster, Build-A-Bear

Subjects
Diagnostic reagents industry -- Securities, Diagnostic reagents industry -- Forecasts and trends, Toy industry -- Securities, Toy industry -- Forecasts and trends, Video stores -- Securities, Video stores -- Forecasts and trends, Market trend/market analysis, Company securities, ImClone Systems Inc. -- Securities, ImClone Systems Inc. -- Forecasts and trends, Blockbuster Inc. -- Securities, Blockbuster Inc. -- Forecasts and trends, Build-A-Bear Workshop -- Securities, Build-A-Bear Workshop -- Forecasts and trends
Published
2008

10. Analyst Actions: Intuit, United Natural Foods, ImClone, Cbeyond; Opinions on various stocks Friday

Subjects
Canned foods industry -- Securities, Canned foods industry -- Forecasts and trends, Diagnostic reagents industry -- Securities, Diagnostic reagents industry -- Forecasts and trends, Telecommunications services industry -- Securities, Telecommunications services industry -- Forecasts and trends, Communications industry -- Securities, Communications industry -- Forecasts and trends, Telecommunications services industry, Company securities, Market trend/market analysis, United Natural Foods Inc. -- Securities, United Natural Foods Inc. -- Forecasts and trends, ImClone Systems Inc. -- Securities, ImClone Systems Inc. -- Forecasts and trends, Cbeyond Communications -- Securities, Cbeyond Communications -- Forecasts and trends
Published
2008

11. S&P PIcks and Pans: Bristol-Myers, Countrywide, Take-Two; Analyst opinions on stocks making headlines Tuesday

Subjects
Pharmaceutical industry -- Securities, Pharmaceutical industry -- Forecasts and trends, Diagnostic reagents industry -- Securities, Diagnostic reagents industry -- Forecasts and trends, Mortgage banks -- Securities, Mortgage banks -- Forecasts and trends, Computer software industry -- Securities, Computer software industry -- Forecasts and trends, Company securities, Market trend/market analysis, ImClone Systems Inc. -- Securities, ImClone Systems Inc. -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Bristol-Myers Squibb Co. -- Securities, Bank of America Home Loans -- Securities, Bank of America Home Loans -- Forecasts and trends, Take-Two Interactive Software Inc. -- Securities, Take-Two Interactive Software Inc. -- Forecasts and trends
Published
2007

12. Movers: Countrywide Financial, ImClone Systems, McDonald's; Tuesday's stocks in the news

Subjects
Pharmaceutical industry -- Securities, Pharmaceutical industry -- Forecasts and trends, Diagnostic reagents industry -- Securities, Diagnostic reagents industry -- Forecasts and trends, Mortgage banks -- Securities, Mortgage banks -- Forecasts and trends, Company securities, Market trend/market analysis, ImClone Systems Inc. -- Securities, ImClone Systems Inc. -- Forecasts and trends, Bank of America Home Loans -- Securities, Bank of America Home Loans -- Forecasts and trends, King Pharmaceuticals Inc. -- Securities, King Pharmaceuticals Inc. -- Forecasts and trends
Published
2007

14. Street Cheers ImClone, but Analysts Remain Wary; The stock gained amid word of a fresh tussle between the drug outfit's board and Carl Icahn, who refused to support a $36 a share buyout bid

Subjects
Diagnostic reagents industry -- Securities, Diagnostic reagents industry -- Company forecasts, Diagnostic reagents industry -- Management, Company securities, Company business forecast/projection, Company business management, ImClone Systems Inc. -- Securities, ImClone Systems Inc. -- Company forecasts, ImClone Systems Inc. -- Management
Published
2006

15. ImClone on the Block; The once-infamous pharmaceutical company has put itself up for sale. What will that mean for its stock?

Author

Rosenbush, Steve

Subjects
Erbitux (Medication) -- Market share, Diagnostic reagents industry -- Securities, Diagnostic reagents industry -- Mergers, acquisitions and divestments, Antimitotic agents -- Market share, Antineoplastic agents -- Market share, Company securities, Company acquisition/merger, Company market share, ImClone Systems Inc. -- Securities, ImClone Systems Inc. -- Mergers, acquisitions and divestments
Published
2006

16. CLOSING BELL: ImClone Systems

Subjects
Company securities, ImClone Systems Inc. -- Securities, Erbitux (Medication) -- Product information, Diagnostic reagents industry -- Securities
Published
2005

18. Closing Bell: ImClone Systems

Subjects
Contract agreement, Company securities, ImClone Systems Inc. -- Securities, Erbitux (Medication) -- Contracts, Diagnostic reagents industry -- Securities
Published
2004

19. A Beat-Up ImClone Looks Good; An earnings 'disappointment' just knocked 20% off its share price. Given its strong growth prospects, that makes the biotech tempting

Author

Tsao, Amy

Subjects
ImClone Erbitux (Medication) -- Forecasts and trends, Diagnostic reagents industry -- Securities, Diagnostic reagents industry -- Company sales and earnings, Market trend/market analysis, Company earnings/profit, Company securities, ImClone Systems Inc. -- Securities, ImClone Systems Inc. -- Company sales and earnings
Published
2004

20. The Second Coming Of ImClone

Subjects
Company legal issue, Company securities, ImClone Systems Inc. -- Securities, Insider trading in securities -- Cases, Businesspeople -- Securities, Entrepreneurship -- Securities, Diagnostic reagents industry -- Securities
Published
2004

22. Is ImClone Out of the Woods? If the FDA approves its Erbitux anticancer treatment, as S&P expects, the biotech's volatile stock should be set for solid growth

Author

DiLorenzo, Frank

Subjects
Diagnostic reagents industry -- Product development, Diagnostic reagents industry -- Securities, Cancer -- Care and treatment, Cancer -- Laws, regulations and rules, Cancer -- Product development, Government regulation, Company securities, ImClone Systems Inc. -- Product development, ImClone Systems Inc. -- Securities
Published
2004

23. Digene's Pap Test May Get an FDA Boost

Author

Marcial, Gene G.

Subjects
Company securities, Digene Corp. -- Securities, Digene Corp. -- Product information, Diagnostic reagents industry -- Securities, Diagnostic reagents industry -- Product information
Published
2003

24. Tiffany Falls on Earnings Forecast; Wyeth shares drop as NIH discontinues hormone replacement therapy group; Citrix sees shortfall; plus more of today's stocks in the news

Subjects
Computer software industry -- Securities, Diagnostic reagents industry -- Securities, Jewelry stores -- Securities, Clothing industry -- Securities, Restaurant industry -- Securities, Chocolate industry -- Securities, Wholesale industry -- Securities, Semiconductor industry -- Securities, Semiconductor production equipment industry -- Securities, Variety stores -- Securities, Clothing stores -- Securities, Coffee industry -- Securities, Mail-order industry -- Securities, Citrix Systems Inc. (Fort Lauderdale, Florida) -- Securities, IGEN International Inc. -- Securities, Tiffany & Co. -- Securities, Retek Information Systems Inc. -- Securities, Jones Apparel Group Inc. -- Securities, Ruby Tuesday Inc. -- Securities, JDA Software Group Inc. -- Securities, Wyeth Co. -- Securities, The Hershey Co. -- Securities, Nautica Enterprises Inc. -- Securities, Intel Corp. -- Securities, Applied Materials Inc. -- Securities, Tuesday Morning Corp. -- Securities, Chico's FAS Inc. -- Securities, AOL Time Warner Inc. -- Securities, J. Jill Group Inc. -- Securities, Starbucks Corp. -- Securities
Published
2002

25. MARTHA STEWART: ALL THIS FOR CHUMP CHANGE?

Subjects
ImClone Systems Inc. -- Securities, Diagnostic reagents industry -- Securities, Insider trading in securities -- Cases, Obstruction of justice -- Cases
Published
2002

26. AirGate Shares Plunge; Tyco may take a charge for CIT sale; Intel shares slide; plus more of today's stocks in the news

Subjects
Diagnostic reagents industry -- Securities, Semiconductor industry -- Securities, Telecommunications services industry -- Securities, Security systems industry -- Securities, ImClone Systems Inc. -- Securities, Intel Corp. -- Securities, Merrill Lynch & Company Inc. -- Securities, Nextel Communications Inc. -- Securities, Sprint Spectrum L.P. -- Securities, Tyco International Ltd. (Pembroke, New Hampshire) -- Securities
Published
2002

27. SECOND CHANCE

Subjects
ImClone Systems Inc. -- Securities, Erbitux (Medication) -- Marketing, Diagnostic reagents industry -- Securities
Published
2002

29. Mega-deal with Bristol-Myers Squibb lifts New York's ImClone

Author

Brower, Vicki

Subjects
ImClone Systems Inc. -- Securities, Bristol-Myers Squibb Co. -- Investments, Diagnostic reagents industry -- Securities, Pharmaceutical industry -- Investments, Biotechnology industry, Business
Published
2001

Catalog

Books, media, physical & digital resources
See catalog results